Key Insights

Highlights

Success Rate

95% trial completion (above average)

Published Results

115 trials with published results (8%)

Research Maturity

842 completed trials (61% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

3.0%

42 terminated out of 1385 trials

Success Rate

95.2%

+8.7% vs benchmark

Late-Stage Pipeline

10%

141 trials in Phase 3/4

Results Transparency

14%

115 of 842 completed with results

Key Signals

115 with results95% success42 terminated

Data Visualizations

Phase Distribution

1,071Total
Not Applicable (800)
Early P 1 (16)
P 1 (35)
P 2 (79)
P 3 (50)
P 4 (91)

Trial Status

Completed842
Unknown240
Recruiting118
Active Not Recruiting48
Not Yet Recruiting45
Terminated42

Trial Success Rate

95.2%

Benchmark: 86.5%

Based on 842 completed trials

Clinical Trials (1385)

Showing 20 of 20 trials
NCT07396792Not Yet Recruiting

Screening for Cardiac and Cardiac-associated Pathology Using Single-channel Electrocardiogram

NCT01326416Not ApplicableCompleted

Evaluation of the Impact of Physical Reconditioning Associated With Specific Nutritional Supplementation in Obese Patients Suffering From Metabolic Syndrome

NCT01566188Not ApplicableCompleted

Vascular Impact of Omega-3 in Metabolic Syndrome

NCT07401888Not ApplicableRecruitingPrimary

A Study Of Milk Consumption In Metabolic Syndrome

NCT07313787Phase 2Not Yet Recruiting

Effects of Meal Macronutrients on Postprandial Lipids

NCT06112418Not ApplicableRecruiting

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

NCT04634591Recruiting

The Bialystok Bariatric Surgery Study

NCT01143480Recruiting

Study of the Effect of Innate on the Inflammatory Response to Endotoxin

NCT07406191Not ApplicableRecruiting

WB-EMS Effects on Cardiometabolic Risk Factors

NCT05806801Not ApplicableRecruiting

Metabolic Adaptations to Weight Loss With and Without Exercise

NCT03113994Phase 2Terminated

Statin Monotherapy for Treatment of Endocrine Metabolic Disease Risk

NCT07306988Phase 4Recruiting

Eradication of Helicobacter Pylori Improves Metabolic Syndrome Through Modulation of Gut Microbiota.

NCT06117631Not ApplicableActive Not Recruiting

Project Sueño: Sleep & Understanding Early Nutrition in Obesity

NCT06271200Not ApplicableRecruitingPrimary

Strategic Lifestyle Intervention for Metabolic Syndrome (SLIM-MET)

NCT07410325Not ApplicableRecruiting

Effectiveness and Implementation of a Community-based Health Coach-led Artificial Intelligence (AI)-Powered Digital Self-Regulation Program for Individuals With Metabolic Syndrome (MetS)

NCT04583514Not ApplicableRecruiting

Testing the Adipose Expandability Hypothesis In Vivo During Overfeeding

NCT07491978Not Yet RecruitingPrimary

Development and Multicenter Validation of an AI-Based Remote Photoplethysmography (rPPG) Facial Scan for Multimodal Health Assessment

NCT04421014Not ApplicableCompletedPrimary

Ketone Ester Effects on Biomarkers of Brain Metabolism and Cognitive Performance in Cognitively Intact Adults 55 Years Old or Older

NCT07505277Not ApplicableRecruitingPrimary

Study of the Effects of Food Formulations Containing Antioxidants, Prebiotic Fibers, and Oat Beta-glucans in Individuals at Risk of Metabolic Syndrome

NCT06703684Completed

TCM Syndrome Differentiation of T2DM & MetS

Scroll to load more

Research Network

Activity Timeline